Daniel J. Liebl, Ph.D.
Professor, Department of Neurological Surgery
Molecular Mechanisms that Regulate Cellular Dysfunction and Death Following CNS Injury; Mechanisms to Promote Regeneration and Recovery
Our overall goal is to achieve a better understanding of how the injured CNS response to traumatic injury, including brain and spinal cord injury. Protecting the brain and spinal cord from progressive damage and promoting restoration are both important for improving patient recovery. My laboratory has focused on four specific areas of interest: (1) identifying a novel mechanism of cell death; (2) stabilizing synaptic connections and re-establishing new synapses; (3) promoting angiogenesis; and (4) enhancement of adult neurogenesis. To examine these functions, we take advantage of genetic mouse models of traumatic brain injury (TBI) and spinal cord injury (SCI), where we can examine the mechanisms of action within a complex and evolving injury environment using loss-of-function, gain-of-function, and return-of-function approaches. In fact, we take great value in employing a comprehensive set of tools for each of our experimental goals, including molecular, biochemical, genetic, cellular, behavioral, and physiological analyzes as well as high-throughput approaches to identify novel regulators of CNS recovery.
SPECIFIC RESEARCH AREAS OF INTEREST INCLUDE:
(1) Synaptic Protection and Regeneration: Many of the functional defects associated with CNS injury result from neuronal death that led to synaptic losses; however, there is also a significant amount synaptic damage even when neurons are not lost. This progressive synaptic damage occurs around the injury site but also in distal regions. We have developed a controlled cortical impact injury mouse model that results in synaptic damage in the hippocampus without neuron cell death to examine synaptic stability, de-innervation and re-innervation. We hypothesize that glial cells in the tripartite synapse play an important role in regulated synaptic stability and promoting recovery, and test our hypotheses using cell specific inducible transgenic mice. We anticipate our findings will lead to novel therapeutic strategies to protect and promote synaptic function in the TBI patient.
(2) Dependence Receptor Cell Death: We have recently identified that Eph receptors are new members of the dependence receptor family, and have implicate these proapoptotic receptors in CNS injury. In non-pathological conditions, dependence receptors play a positive role in CNS development and/or adult homeostasis upon ligand interactions. However, in the absence of ligand stimulation and following stress, Eph receptors undergo conformational alterations that lead to its conversion to a death receptor. In addition to identifying their roles in CNS injury, we are interested in understanding the signaling cascades, mechanism of induction, and strategies to block Eph-mediated cell death. Our studies will have direct implications on protecting the nervous system fr progressive cell loss after injury.
(3) Adult Angiogenesis: There has been a great deal of research in understanding the blood brain barrier, but little understanding of the mechanism that regulate angiogenic sprouting and growth after CNS injury. Much of our current knowledge comes the developing nervous system and vascularization in tumors. Interestingly, the growing endothelial sprout has many characteristics similar to a growing axon sprout, which we can learn from. Our interest is to define the role of angiogenesis in the injured adult CNS, and determine whether new growth can be stimulated. We employ cutting edge technologies, including light-sheet microscopy, to examine vessel dynamics in 3 dimensions, which is important for understanding how vascular growth relates to various brain structures and function.
(4) Adult Neurogenesis: We have recently demonstrated new and novel functions for ephrins and Eph receptors in adult neurogenesis, where they function to maintain proper stem/progenitor cell numbers by regulating proliferation, migration, and survival. Enhancing residential cell replacement strategies provides an attractive approach for stem cell therapy.
Daniel J. Liebl, Ph.D.
- The Miami Project to Cure Paralysis
1095 NW 14th Terrace (R-48)
Miami, FL 33136
- (305) 243-8183
- (305) 243-3914
A Moment with Dalton – Dr. Dan Liebl (February 2020)
|Madelen Diaz||Post-Doctoral Fellowfirstname.lastname@example.org|
|Maria Cepero||Research Associateemail@example.com|
|Jose Meir||Research Analystfirstname.lastname@example.org|
|Maria Magdalena Quiala||Senior Research Assistantemail@example.com|
|Maureen Ascona||Graduate Studentfirstname.lastname@example.org|
|Dena Arizanovska||Graduate Studentemail@example.com|
|Stephen Tapanes||Graduate Studentfirstname.lastname@example.org|